(Q38155132)

29 August 2017

Neuromelanin of the human substantia nigra: an update (English)

1 reference

29 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Francesca A Cupaioli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Emanuele Ferrari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

2

Emy Basso

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

7

Luigi Zecca

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Luigi Casella

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

David Sulzer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

1 reference

24 October 2013

1 reference

29 August 2017

Neurotoxicity Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

13-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12640-013-9435-y

3 June 2020

exact match

0 references

cites work

EPR investigations of the iron domain in neuromelanin.

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Studies on neuromelanin. I. A melanin system in the human adult brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Intracellular chemical imaging of the developmental phases of human neuromelanin using synchrotron X-ray microspectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

The structure of neuromelanin and its iron binding site studied by infrared spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanic pigment in substantia nigra neurons of rats and dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Increased nigral iron content in postmortem parkinsonian brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Influence of neuromelanin on oxidative pathways within the human substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Iron-binding characteristics of neuromelanin of the human substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanins of human brain have soluble and insoluble components with dolichols attached to the melanic structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Modifications of the iron-neuromelanin system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Dolichol is the major lipid component of human substantia nigra neuromelanin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Investigation of the lipid component of neuromelanin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Epinephrine metabolites and pigmentation in the central nervous system in a case of phenylpyruvic oligophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Studies on neuromelanin: II. Melanin in the brainstems of infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

On the nature of pigment granules in the cells of the locus coeruleus and substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Evidence for specific phases in the development of human neuromelanin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Encapsulation of a reactive core in neuromelanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Chemistry of mixed melanogenesis--pivotal roles of dopaquinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Melanin affinity and its possible role in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells--a possible link between Parkinson-dementia complex and pigmentary retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

X-ray absorption fine-structure spectroscopy studies of Fe sites in natural human neuromelanin and synthetic analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Interaction between chemicals and melanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanin and its possible protective and destructive properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

The role of vesicular transport proteins in synaptic transmission and neural degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Structures for amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Preservation of hypothalamic dopaminergic neurons in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Aging and Extrapyramidal Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

The physical and chemical properties of eumelanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Glutathione redox status in mitochondria and cytoplasm differentially and sequentially activates apoptosis cascade in dopamine-melanin-treated SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Myoglobin modification by enzyme-generated dopamine reactive species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanin is an immune stimulator for dendritic cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Long-term retention of neurotoxic beta-carbolines in brain neuromelanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanin synthesis in rat and human substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson??s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Intraneuronal dopamine-quinone synthesis: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Modulation by neuromelanin of the availability and reactivity of metal ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Effects of paraquat on mitochondrial electron transport system and catecholamine contents in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanin inhibits CXCL10 expression in human astroglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

"Subcellular proteomics" of neuromelanin granules isolated from the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Spectroscopic studies of substantia nigra pigment in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Advanced chemical methods in melanin determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

The structure of neuromelanin as studied by chemical degradative methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Identification and quantification of dolichol and dolichoic acid in neuromelanin from substantia nigra of the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Tyrosinase mRNA is expressed in human substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Effects of paraquat on mitochondria of rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-013-9435-Y

Binding of dopaminergic drugs by the neuromelanin of the substantia nigra, synthetic melanins and melanin granules

21 January 2018

1 reference

12 December 2020

Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study

1 reference

12 December 2020

Structural Characteristics of Human Substantia Nigra Neuromelanin and Synthetic Dopamine Melanins

1 reference

12 December 2020

Paramagnetic metal scavenging by melanin: MR imaging

1 reference

12 December 2020

Possible role of neuromelanin in the pathogenesis of Parkinson's disease

1 reference

12 December 2020

Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease

1 reference

12 December 2020

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia

1 reference

12 December 2020

1 reference

12 December 2020

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1 reference

12 December 2020

Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease.

1 reference

12 December 2020

Prostaglandin H synthetase-mediated metabolism of dopamine: implication for Parkinson's disease.

1 reference

12 December 2020

Catecholamines oxidation by xanthine oxidase

1 reference

12 December 2020

Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease

1 reference

12 December 2020

Neuromelanin and Parkinson's disease

1 reference

12 December 2020

Anatomical localisation of neuromelanin in the brains of the frog and tadpole. Ultrastructural comparison of neuromelanin with other melanins.

1 reference

12 December 2020

Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis

1 reference

12 December 2020

The melanoneurons of the human cerebellum (nucleus pigmentosus cerebellaris) and homologues in the monkey.

1 reference

12 December 2020

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

1 reference

12 December 2020

The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease

1 reference

12 December 2020

T1-Weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease

1 reference

12 December 2020

Interaction of neuromelanin and iron in substantia nigra and other areas of human brain

1 reference

12 December 2020

Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain.

1 reference

12 December 2020

Enzymatic dopamine peroxidation in substantia nigra of human brain

1 reference

12 December 2020

1 reference

12 December 2020

Pigmentation in the nucleus substantiae nigrae of mammals.

1 reference

12 December 2020

Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: accumulation in neuromelanin

1 reference

12 December 2020

L-DOPA is a substrate for tyrosine hydroxylase

1 reference

12 December 2020

A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker

1 reference

12 December 2020

Enzymatic oxidation of dopamine: the role of prostaglandin H synthase

1 reference

12 December 2020

Biosynthetic pathway to neuromelanin and its aging process

1 reference

12 December 2020

Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.

1 reference

12 December 2020

The histochemical distribution and localization of copper, iron, neuromelanin and lysosomal enzyme activity in the brain of aging rhesus monkey and the dog

1 reference

12 December 2020

Relationship of golgi thiaminepyrophosphatase and lysosomal acid phosphatase to neuromelanin and lipofuscin in cerebral neurons of the aging rhesus monkey

1 reference

12 December 2020

The role of peroxidase in neuromelanin synthesis: a review.

1 reference

12 December 2020

Preservation of midbrain catecholaminergic neurons in very old human subjects

1 reference

12 December 2020

Whole-body lifetime occupational lead exposure and risk of Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S12640-013-9435-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

3 June 2020

1002876549

0 references

Fatcat ID

release_fuauajezpvha7admtpjmdluuye

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fuauajezpvha7admtpjmdluuye

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24155156%20AND%20SRC:MED&resulttype=core&format=json